Navigation Links
Phoenix conference highlights TGen's and Scottsdale Healthcare's contributions to molecular oncology

PHOENIX, Ariz. Jan. 8, 2009 Physician-scientists from the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare will present their latest findings and techniques at a national conference designed to provide cancer doctors with new treatments for their patients.

"Molecular Oncology: The Sixth Vital Sign, What Every Oncologist Should Know" is intended to help cancer doctors provide better diagnosis, early detection as well as drugs and other treatments that in some cases can slow the growth or even shrink tumors.

"Given the explosion of new information on the genetic and cellular features of malignancy, the modern oncologist must master the significance and application of cancer-related sciences,'' said Dr. Ramesh K. Ramanathan, Medical Director of TGen Clinical Research Services at Scottsdale Healthcare, a partnership between TGen and Scottsdale Healthcare Corp.

Beyond the five vital signs of pulse, respiration, temperature, blood pressure and pain, is a new sixth vital sign molecular therapeutics. This is the ability to identify the causes of disease at the molecular level in order to provide the right drugs in the right amounts at the right times for the specific needs of individual patients; what is becoming better known in health circles as personalized medicine.

"This gap in knowledge and its application in clinical practice will be addressed in this conference,'' said Dr. Ramanathan, a Senior Investigator at TGen.

Dr. Ramanathan is the co-program director of the conference, along with Dr. Daniel Von Hoff, TGen's Physician-In-Chief and the Chief Scientific Officer at TCRS. Both doctors conduct groundbreaking personalized-medicine research and clinical drug trials at TCRS in Scottsdale, and both are on the clinical faculty of the University of Arizona College of Medicine. Both will present at the conference.

Other TGen and Scottsdale Healthcare scientists scheduled to present include: Dr. Jeffrey Trent, TGen's President and Scientific Director; Dr. Raoul Tibes, Director of the Hematological Malignancies Program at TCRS and an Associate Investigator at TGen; Dr. Stephen P. Anthony, Chief Medical Officer of TGen Drug Development Services (TD2) and a Senior Investigator at TGen; Dr. John Carpten, Director of TGen's Integrated Cancer Genomics Division and a Senior Investigator at TGen; and Gayle Jameson, M.S.N., Director of Supportive Care at TCRS and an Associate Investigator at TGen.

Besides oncologists, the target audience includes all physicians and health professionals involved in caring for cancer patients, and researchers interested in new cancer diagnostics and therapeutics.

Key objectives of the conference include:

  • Explaining the molecular and cellular features of malignancy in diagnostic and therapeutic approaches to the treatment of cancer, and identifying new diagnostic tools.

  • Assessing the effects and early clinical results of new, targeted drug therapies on solid tumors and malignant blood cancers.

  • Identifying new drug therapies that optimize treatment results and minimize side effects in specific biologic and clinical scenarios.

  • Evaluating clinical trials and translational methods of care and their proper use in clinical decision-making and patient management.


Contact: Steve Yozwiak
The Translational Genomics Research Institute

Related biology news :

1. Phoenix mission to Mars will search for climate clues
2. Atmel and Phoenix Technologies Collaborate to Create Next-generation Security Solutions for PCs
3. Phoenix Technologies and Atmel Collaborate to Create Next-Generation Security Solutions for PCs
4. Harmonizing Biobank Research Conference in 2009
5. PNNL researchers earn top honors at Supercomputing conference
6. Conference to explore sustainability of biofuels
7. Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25
8. Major conference on food Dec. 1-2, 2008
9. PNNL leadership in carbon sequestration featured at international conference
10. Engineer to present leak-proof method for carbon dioxide storage at international conference
11. Marine invasive species advance 50 km per decade, World Conference on Marine Biodiversity told
Post Your Comments:
(Date:11/17/2015)... Calif. , Nov. 17, 2015  Vigilant Solutions ... has joined its Board of Directors. ... Board after recently retiring from the partnership at TPG ... 107 companies with over $140 Billion in revenue.  He ... improvement across all the TPG companies, from 1997 to ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
(Date:11/9/2015)... JOSE, Calif. , Nov. 9, 2015  Synaptics ... human interface solutions, today announced broader entry into the ... vehicle-specific solutions that match the pace of consumer electronics ... and biometric sensors are ideal for the automotive industry ... vehicle. Europe , ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... , November 30, 2015 TapImmune, ... the development of innovative peptide and gene-based immunotherapeutics and ... today announced it will be presenting at the 8 ... 1, 2015 at 2.30 PM PT. Dr. John ... Advisor will be giving the presentation and will join ...
(Date:11/30/2015)... and MAGDEBURG, Germany , November 30, 2015 ... in Vienna, Austria to be ... of NeuroRehabilitation (ECNR) in Vienna, Austria ... NovaVision, a wholly owned subsidiary of Vycor Medical, Inc. ("Vycor") ... its Internet-delivered NovaVision Therapy Suite at the 3rd European ...
(Date:11/28/2015)... ... November 28, 2015 , ... • Jeon Jin Bio Corp, a ... rodent control solutions , Bird Free, an ... across all sensory modalities including visual, smell, taste and touch, enabling safe, effective avian ...
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
Breaking Biology Technology: